Northera

Chemical Namedroxidopa
Dosage FormCapsules (oral; 100 mg, 200 mg, 300 mg)
Drug ClassUnknown mechanism of action
SystemCardiovascular
CompanyLundbeck
Approval Year2014

Indication

  • For the treatment of orthostatic dizziness and light-headedness in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropath.
Last updated on 11/14/2022

More on this drug: Clinical Trials

Document TitleYearSource
Northera (droxidopa) Prescribing Information. 2019Lundbeck, Deerfield, IL